Volume 31, No 12, Dec 2021

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 31 Issue 12, December 2021: 1226-1227

RESEARCH HIGHLIGHTS

Novel attempts launched toward universal Sarbecovirus vaccine

Haoyang Li¹ , Erica Ollmann Saphire^1,2,*

¹Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, USA
²Department of Medicine, University of California San Diego, La Jolla, CA, USA
Correspondence: Erica Ollmann Saphire(erica@lji.org)

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and new coronaviruses raise the demand for universal vaccines. In recent Science and Cell papers, Martinez et al. and Nathan et al. reported two novel approaches for vaccine design based on structural analysis on the immunogens to achieve better elicitation of broad B cell or T cell responses against Sarbecoviruses, respectively.

https://doi.org/10.1038/s41422-021-00556-z

FULL TEXT | PDF

Browse 871